Last reviewed · How we verify

NCT04360863

The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong

Status unknown Last updated 4 November 2020
What this trial tests

trial testing Telephone survey in Smoking Cessation in 150 participants. Status unknown.

Timeline
24 April 2020
Primary endpoint
30 December 2021
30 December 2021

Quick facts

Lead sponsorThe University of Hong Kong
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date24 April 2020
Primary completion30 December 2021
Estimated completion30 December 2021
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

Adults 0 to 25, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of the present study are: 1. To explore the impact of COVID-19 pandemic on the smoking behavior of youth smokers 2. To explore the impact of COVID-19 pandemic on the Youth Quitline service in Hong Kong

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Telephone survey

Trials testing the same drug.

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04360863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing